CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate
Pill imprint CYP 517 has been identified as Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg.
Uritact-EC is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)
- Generic Name:
- hyoscyamine/methenamine/methylene blue/phenyl salicylate
- 0.06 mg-81.6 mg-10.8 mg-36.2 mg
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Cypress Pharmaceutical Inc
Uritact-EC is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...